progress

Zymeworks Inc . (NYSE: NASDAQ:) reported its financial results for the third quarter of 2024, revealing a net loss of $99.2 million, which is a slight improvement from the $104.2 million loss in the same period last year. The company, which specializes in the development of innovative cancer treatments, has…

Innate Pharma (Euronext Paris: IPH) has presented its first-half 2024 financial results and clinical pipeline updates in an earnings call held in October 2023. The company, which is currently without a permanent CEO, reported advancements in its oncology-focused drug development, including the orphan drug designated lacutamab, and a robust pipeline…

Unifi, Inc. (NYSE: NYSE:), a global textile solutions provider, reported a mixed fiscal fourth quarter in 2024, with sales surpassing previous quarters and the same period last year, despite a slower recovery in the textile and apparel industry. The company’s EBITDA stood at $5.9 million, with a focus on innovation…

Precipio, Inc. (NASDAQ:), a diagnostic services and products company, reported continued revenue growth in its Q2 2024 earnings call, with its pathology division reaching breakeven at the end of the quarter. CEO Ilan Danieli expressed confidence in the company’s trajectory, emphasizing progress in both the pathology and product divisions. The…

In the second quarter of 2024, Boralex (BLX.TO) announced a solid financial performance with increased EBITDA, operating income, and net earnings in comparison to the previous year. The company is advancing with 851 megawatts of secured projects, including the Apuiat project in Quebec and the Limekiln project in Scotland. Despite…